Peptide record

TPDB11366

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
32 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11366
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF AFP-GFuse Antifungipept CAFPdb i2APP AI4AVP dbAMP 3.0 DRAVP 2.0 APD_complete PD_Hemolysis ToxinPred 3.0
standard
No
A 32-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
ATCYCRTGRCATRESLSGVCEISGRLYRLCCR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C144H244N50O45S6
NDQHKMFPW
RC
3588.19
8.59
6
2
9
+4
2.61
-0.113
64.06
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
3355
0.94
14
Residue Composition
number
2
A
6
R
0
N
0
D
6
C
2
E
0
Q
3
G
0
H
1
I
3
L
0
K
0
M
0
F
0
P
3
S
3
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 2 R: 6 N: 0 D: 0 C: 6 E: 2 Q: 0 G: 3 H: 0 I: 1 L: 3 K: 0 M: 0 F: 0 P: 0 S: 3 T: 3 W: 0 Y: 2 V: 1
Chemical Descriptors
32 reviewed residue count
C144H244N50O45S6 sequence-only estimate (linear, free termini)
3588.19 sequence-only estimate (linear, free termini)
8.59 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
2.61 sequence-only estimate (linear, free termini)
-0.113 sequence-only estimate (linear, free termini)
Evidence Records 17 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4.7 µg/mL

Target

Escherichia coli ML35 ATCC 43827

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli ML35 ATCC 43827 (MIC 4.7 ug/ml) and S. aureus ATCC 25923 (MIC 1.9 ug/ml) (ref, see reduced form SAR). Killed C. difficile
Evidence 2 Activity

Activity

MIC
Antibacterial
1.9 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP DRAMP

Other

Active against E. coli ML35 ATCC 43827 (MIC 4.7 ug/ml) and S. aureus ATCC 25923 (MIC 1.9 ug/ml) (ref, see reduced form SAR). Killed C. difficile. Human HD5 blocks papillomavirus infecti
Evidence 3 Activity

Activity

MIC
Antifungal
4.7 µg/mL

Target

Escherichia coli ML35 ATCC 43827

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli ML35 ATCC 43827 (MIC 4.7 ug/ml) and S. aureus ATCC 25923 (MIC 1.9 ug/ml) (ref, see reduced form SAR). Killed C. difficile
Evidence 4 Activity

Activity

MIC
Antifungal
1.9 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli ML35 ATCC 43827 (MIC 4.7 ug/ml) and S. aureus ATCC 25923 (MIC 1.9 ug/ml) (ref, see reduced form SAR). Killed C. difficile. Human HD5 blocks papillomavirus infecti
Evidence 5 Activity

Activity

MIC
Antiparasitic
4.7 µg/mL

Target

Escherichia coli ML35 ATCC 43827

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E. coli ML35 ATCC 43827 (MIC 4.7 ug/ml) and S. aureus ATCC 25923 (MIC 1.9 ug/ml) (ref, see reduced form SAR). Killed C. difficile
Evidence 6 Activity

Activity

MIC
Antiparasitic
1.9 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli ML35 ATCC 43827 (MIC 4.7 ug/ml) and S. aureus ATCC 25923 (MIC 1.9 ug/ml) (ref, see reduced form SAR). Killed C. difficile. Human HD5 blocks papillomavirus infecti
Evidence 7 Activity

Activity

MIC
Antiviral
4.7 µg/mL

Target

Escherichia coli ML35 ATCC 43827

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against E. coli ML35 ATCC 43827 (MIC 4.7 ug/ml) and S. aureus ATCC 25923 (MIC 1.9 ug/ml) (ref, see reduced form SAR). Killed C. difficile
Evidence 8 Activity

Activity

MIC
Antiviral
1.9 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against E. coli ML35 ATCC 43827 (MIC 4.7 ug/ml) and S. aureus ATCC 25923 (MIC 1.9 ug/ml) (ref, see reduced form SAR). Killed C. difficile. Human HD5 blocks papillomavirus infecti
Evidence 9 Activity

Activity

Toxicity
Hemolytic
NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs. | Peptides | 2015
Evidence 10 Activity

Activity

20% Hemolysis
Toxicity
25 µg/mL
Hemolytic Cytotoxic
20% Hemolysis | 25 | µg/mL | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii. | Antimicrob Agents Chemother | 2018
Evidence 11 Activity

Activity

33% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
33% Hemolysis | 50 | µg/mL | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii. | Antimicrob Agents Chemother | 2018
Evidence 12 Activity

Activity

40% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
40% Hemolysis | 100 | µg/mL | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii. | Antimicrob Agents Chemother | 2018
Evidence 13 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii. | Antimicrob Agents Chemother | 2018
Evidence 14 Activity

Activity

50% Cytotoxicity
Toxicity
24 µM
Cytotoxic
50% Cytotoxicity | 24 | µM | target cell: Human retinal epithelial cells ARPE-19

Target

Human retinal epithelial cells ARPE-19

Source & Reference

NA
DBAASP
The Human ?-Defensin-Derived Peptide HD5(1-9) Inhibits Cellular Attachment and Entry of Human Cytomegalovirus | Antiviral Res | 2020
Evidence 15 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Human cervical epithelial cells CaSki

Target

Human cervical epithelial cells CaSki

Source & Reference

NA
DBAASP
Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites. | J Virol | 2013
Evidence 16 Activity

Activity

% Hemolysis
Toxicity
0 %
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.26206286] It has 0% hemolysis at 100µM against human red blood cells. | Cytotoxicity: [Ref.34206990]No cytotoxicity on HEK293T cells up to 50 µg/mL.

Target

erythrocytes

Source & Reference

NA
DRAMP
Viruses. 2021 Jun 26 13(7):1246.##Nat Immunol. 2002 Jun 3(6):583-590.##Antimicrob Agents Chemother. 2005 Jan 49(1):269-275.##Peptides. 2015 Sep 71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.
Evidence 17 Hemolysis

Source & Reference

APD_complete PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.